Search
for
Sort by
Research 961–990 of 1000+
- Decoding the ZmNF-YC1–ZmAPRG pathway for phosphorus efficiency
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- 676 Wnt and SHH interact to determine hair follicle dermal condensate fate
- Plant elicitor Peptides regulate root hair development in Arabidopsis
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Gynecological and dermatological aspects of diagnostics of polycystic ovary syndrome from puberty to menopause
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- Acute and Chronic Telogen Effluvium
- Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism
- Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence
- 58-Year-Old Female with Diffuse Thinning of the Hair
- PRP in Combination Therapy for Hair Loss (AGA)
- Hair Restoration
- Author response: ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
- Decision letter: ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
- Acute and Chronic Telogen Effluvium
- Under‐Explored Species, Breeds and Cell Types With Potential for Cultivated Meat Production
- Protective Effects of Shallot (Allium ascalonicum) Extracts Against PAH-Induced Oxidative Stress in Human Nasal Epithelial Cells
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- CROSS-META-ANALYSIS ON POLICOSANOL BIOREFINING: AN INNOVATIVE TECHNOLOGY PROSPECTING PROTOCOL WITH IBERO-AMERICAN INSIGHTS
- Topical Application of Bio-Pulsed Avian MSC-Derived Extracellular Vesicles Enhances Hair Regrowth and Skin Rejuvenation: Evidence from Clinical Evaluation and miRNA Profiling
- Anti-hair loss and hair care properties from tropical halophyte, seablite (Suaeda maritima) root extract
- 8507 Misdiagnosis of Graves’ and RAI Treatment in Patient with THRB Gene Mutation
- 686 Topical melatonin unfolds differential anti-aging effects in human skin by inhibiting mTORC1 activity via TSC2 stimulation
- Potential Biomolecule Fisetin: Molecular and Pharmacological Perspectives
- Iron Supplementation May Improve the Patient’s Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study
- Deferoxamine protects cochlear hair cells and hair cell-like HEI-OC1 cells against tert-butyl hydroperoxide-induced ototoxicity
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis